American Brain Tumor Association Announces $1.3 Million in New Funding to Accelerate Adult and Pediatric Brain Tumor Research
08 Nov 2023
With more than $35 million invested across 800 research projects, the ABTA is at the forefront of driving progress and seeding hope for life-changing treatments and care for brain tumor patients.
CHICAGO, Nov. 8, 2023 /PRNewswire/ -- The American Brain Tumor Association (ABTA) today announced the funding of $1.37 million towards 23 new research grants to advance brain tumor science and treatments, across all brain tumor types and ages. Dedicated to advancing the field of neuro-oncology and accelerating the discovery of life-saving treatments, the ABTA is proud to have invested more than $35 million, to approximately 700 researchers and 800 projects, to date.
Continue Reading
"Throughout our 50-year history, the ABTA has provided vital seed money to fund collaborative and high-risk, high-reward research grants which have contributed to significant breakthroughs in treating brain tumors by many of the country's leading researchers," said Nicole Willmarth, Ph.D., ABTA's chief mission officer. "We are excited to empower a new class of grant recipients whose bold visions have the potential to unlock new opportunities in the fight against brain tumors."
ABTA's high-risk, high-reward research grants have contributed to significant breakthroughs in treating brain tumors.
Post this
This year's slate of research projects investigates biomarkers, DNA damage and repair mechanisms, gene therapies, and more, across adult and pediatric primary brain tumors and metastatic brain cancers.
The ABTA congratulates the 2023 grant recipients listed below. To learn more about ABTA grant recipients and their research projects, visit www.abta.org/research/research-funding-impact/.
Research Collaboration Grants are two-year, $200,000 grants awarded for multi-investigator and multi-institutional brain tumor collaborative research projects. They are intended to promote team science, streamlining, and accelerating research progress.
Federico Gaiti, PhD—University Health Network, Canada
Gelareh Zadeh, MD, PhD, FRCSC, FAANS—University of Toronto, Canada
Oliver Jonas, PhD—Brigham and Women's Hospital, Massachusetts
Shawn Hervey-Jumper, MD—University of California, San Francisco, California
Derek Wainwright, PhD—Loyola University of Chicago, Illinois
Pilar Sanchez-Gomez, PhD—Instituto de Salud Carlos III, Spain
Basic Research Fellowships are two-year, $100,000 grants awarded to post-doctoral fellows who are mentored by established and nationally recognized experts in the neuro-oncology field.
Charuta Furey, MD—Barrow Neurological Institute, St. Joseph Medical Center, Arizona
Juyeun Lee, PhD, DVM—Cleveland Clinic, Ohio
Rakesh Trivedi, PhD—MD Anderson Cancer CenterCancer Center, Texas
Discovery Grants are one-year, $50,000 grants supporting high-risk, high-reward innovative approaches that hold potential to change current diagnostic or treatment standards of care.
Theresa Barberi, PhD—Johns Hopkins University School of Medicine, Maryland
Defne Bayik, PhD—Sylvester Comprehensive Cancer Center/University of Miami Health Systems, Florida
Phedias Diamandis, MD, PhD—University Health Network, Canada
Siddharthra Mitra, PhD—University of Colorado Denver, Colorado
Allegra Petti, PhD—Massachusetts General Hospital, Massachusetts
Soma Sengupta, MD, PhD—University of North Carolina at Chapel Hill, North Carolina
Daniel Silver, PhD—Cleveland Clinic, Ohio
Elizabeth Sweeney, PhD—The George Washington University, District of Columbia
Nehalkumar Thakor, PhD—The University of Lethbridge, Canada
Medical Student Summer Fellowships are three-month, $3,000 grants awarded to medical students to conduct brain tumor research projects under the guidance of neuro-oncology experts. Through these grants, the ABTA seeks to encourage physician-scientists to enter and remain in the brain tumor field.
Michael Chang, BS—Johns Hopkins University School of Medicine, Maryland
Himanshu Dashora, BS—Cleveland Clinic, Ohio
Jakub Jarmula, BA—Cleveland Clinic, Ohio
Jenna Koenig, BS—Indiana University, Indiana
Jayson Nelson, BS—The University of Utah, Utah
Minh Nguyen, BS—University of California, San Francisco, California
Gabrielle Price, MSc—Icahn School of Medicine at Mount Sinai, New York
Sangami Pugazenthi, BA—Washington University in St. Louis, Missouri
Awarding of these grants would not be possible without the incredible support of our donors and our partner organizations including the Joel A. Gingras Memorial Foundation, Southeastern Brain Tumor Foundation, Brain Up, Brain Tumor Foundation of Canada, Tap Cancer Out, Gladiator Project and StacheStrong.
The ABTA is now accepting applications for its 2024 Research Collaboration Grants, Discovery Grants, Basic Research Fellowships, and Jack and Fay Netchin Medical Student Summer Fellowships. For more information on grant opportunities and deadlines, visit https://www.abta.org/grants/.
About the American Brain Tumor Association
Founded in 1973, the American Brain Tumor Association provides comprehensive resources to support the complex needs of brain tumor patients and caregivers, across all ages and tumor types, as well as the critical funding of research in the pursuit of breakthroughs in brain tumor diagnoses, treatments, and care. To learn more, visit, abta.org or call 800-886-ABTA (2282).
SOURCE American Brain Tumor Association
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.